(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 8. smp regulates Ol-pou5f1 expression.
(A,B) Transverse sections, after WMISH, showing
Ol-pou5f1 expression in early gastrula embryos after smpMO
injection (8 mg/ml). Decreased expression was observed in deep cells, but not
in the EVL of injected embryos (arrowhead). (C-F) Embryos injected at
the 32-cell stage with EGFP RNA (100 µg/ml), either alone (C,E) or
together with smpRNA (500 µg/ml, D,F). At mid-gastrulation (C,D,
dorsal view), no apparent modifications can be observed (white dotted lines
indicate the blastoderm margin). At the 2-somite stage (E,F, dorsal view),
fluorescent cells are excluded from the embryo axis and are found near the
anterior body axis. (G) Lateral view of a 2-somite stage control embryo
showing Ol-pou5f1 expression in telencephalon (t) and tailbud (tb).
(H,I) Ol-pou5f1 expression at the 2-somite stage after
smpRNA injection into two-cell stage embryos. (H) Ectopic expression
is visible in the telencephalon (t), ventral mhb and rhombencephalic domains
(rb). (I) A more widespread expression is observed in strongly affected
embryos. (J-O) Tranverse sections of WMISH embryos. (J-L) Control
embryos. Ol-pou5f1 CNS expression is restricted to the dorsal
telencephalon (arrowhead). (M-O) After injection of smpRNA, ectopic
Ol-pou5f1 expression was observed in telencephalon (M, arrowhead),
and in the ventral mhb (N, arrowhead) and rhombencephalon (O). Scale bars: 30
µm.